Providence Centralia Diabetes Centralia, WA - 98531

Providence Centralia Diabetes is categorized under Outpatient Drug Clinics in Centralia, WA and active since 1998.

Providence Centralia Diabetes was established in 1998, and today employs 1 to 4, earning Unknown per year. This is a Outpatient Drug Clinics business, which does work in the B2C market, and is classified as a Outpatient Drug Clinics, under code number 6241200 by the NAICS.

If you are seeking more information, feel free to contact Melissa Kirk, Manager at the company’s branch by writing to 1010 South Scheuber Road, Centralia, Washington WA 98531 or by phoning (360) 807-7907. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Providence Centralia Diabetes
Contact Person: Melissa Kirk, Manager
Address: 1010 South Scheuber Road, Centralia, Washington 98531
Phone Number: (360) 807-7907
Website Address: providence.org
Annual Revenue (USD): Unknown
Founded: 1998
Location Type: Branch
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Outpatient Drug Clinics
SIC Code: 8093
NAICS Code: 6241200
Share This Business:

Providence Centralia Diabetes was started in 1998 to provide professional Outpatient Drug Clinics under the SIC code 8093 and NAICS code 6241200. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Melissa Kirk, Manager for inquiries that concern Providence Centralia Diabetes by calling the company number (360) 807-7907, as your correspondence is most welcome. Additionally, the physical location of the branch of Providence Centralia Diabetes can be found at the coordinates 46.71205,-122.98692 as well as the street address 1010 South Scheuber Road in Centralia, Washington 98531.

For its online presence, you may visit Providence Centralia Diabetes’s website at providence.org and engage with its social media outlets through on Twitter and on Facebook.